Danaher Co. (DHR) Position Lifted by State of Alaska Department of Revenue

State of Alaska Department of Revenue lifted its position in shares of Danaher Co. (NYSE:DHR) by 1.2% during the fourth quarter, HoldingsChannel reports. The firm owned 96,398 shares of the conglomerate’s stock after acquiring an additional 1,109 shares during the period. State of Alaska Department of Revenue’s holdings in Danaher were worth $9,939,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nissay Asset Management Corp Japan ADV lifted its position in shares of Danaher by 2.4% during the third quarter. Nissay Asset Management Corp Japan ADV now owns 71,651 shares of the conglomerate’s stock valued at $7,786,000 after purchasing an additional 1,651 shares in the last quarter. Inverness Counsel LLC NY lifted its position in shares of Danaher by 0.5% during the third quarter. Inverness Counsel LLC NY now owns 416,828 shares of the conglomerate’s stock valued at $45,293,000 after purchasing an additional 1,951 shares in the last quarter. Bainco International Investors lifted its position in shares of Danaher by 2.6% during the third quarter. Bainco International Investors now owns 66,878 shares of the conglomerate’s stock valued at $7,267,000 after purchasing an additional 1,725 shares in the last quarter. First Midwest Bank Trust Division lifted its position in shares of Danaher by 18.2% during the third quarter. First Midwest Bank Trust Division now owns 6,462 shares of the conglomerate’s stock valued at $702,000 after purchasing an additional 993 shares in the last quarter. Finally, Private Wealth Partners LLC lifted its position in shares of Danaher by 14.3% during the second quarter. Private Wealth Partners LLC now owns 95,800 shares of the conglomerate’s stock valued at $9,454,000 after purchasing an additional 11,961 shares in the last quarter. 77.03% of the stock is currently owned by institutional investors.

A number of research analysts recently weighed in on the stock. Robert W. Baird dropped their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday, October 19th. Cowen restated a “buy” rating and set a $110.00 price objective on shares of Danaher in a report on Monday. Morgan Stanley raised their price objective on shares of Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, October 10th. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Friday, October 12th. Finally, Needham & Company LLC initiated coverage on shares of Danaher in a report on Wednesday, January 2nd. They set a “buy” rating and a $114.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $112.28.

In related news, CFO Daniel L. Comas sold 36,000 shares of the business’s stock in a transaction that occurred on Thursday, November 8th. The shares were sold at an average price of $103.88, for a total transaction of $3,739,680.00. Following the completion of the transaction, the chief financial officer now owns 124,218 shares of the company’s stock, valued at $12,903,765.84. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of the business’s stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $95.77, for a total transaction of $1,013,055.06. Following the transaction, the director now directly owns 105,491 shares of the company’s stock, valued at approximately $10,102,873.07. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 150,007 shares of company stock valued at $15,202,163. 11.90% of the stock is owned by corporate insiders.

DHR opened at $105.36 on Friday. The stock has a market capitalization of $73.15 billion, a PE ratio of 26.14, a price-to-earnings-growth ratio of 1.91 and a beta of 1.00. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08. Danaher Co. has a twelve month low of $91.84 and a twelve month high of $110.86.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. The firm had revenue of $4.85 billion during the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. The company’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company earned $1.00 earnings per share. On average, equities research analysts anticipate that Danaher Co. will post 4.51 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 25th. Investors of record on Friday, December 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Thursday, December 27th. This represents a $0.64 annualized dividend and a yield of 0.61%. Danaher’s dividend payout ratio is currently 15.88%.

COPYRIGHT VIOLATION WARNING: “Danaher Co. (DHR) Position Lifted by State of Alaska Department of Revenue” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.com-unik.info/2019/01/11/danaher-co-dhr-position-lifted-by-state-of-alaska-department-of-revenue.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

See Also: What is Cost of Debt?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit